Page last updated: 2024-09-03

pramipexole and Anhedonia

pramipexole has been researched along with Anhedonia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Escalona, R; Laubenthal, CE; Welch, JE1
Asp, M; Björkstrand, J; Deierborg, T; Eklund, M; Jensen, J; Lindahl, J; Lindqvist, D; Månsson, K; Ståhl, D; Svensson, M; Tjernberg, J; Tornberg, Å; van Westen, D; Ventorp, F1
Dutra, RC; Felipetti, FA; Gonçalves, ECD; Horewicz, VV; Lieberknecht, V; Martins, DF; Rabelo, BD; Rodrigues, ALS1
Boulet, S; Carcenac, C; Carnicella, S; David, O; Krack, P; Magnard, R; Savasta, M; Vachez, Y1
Escalona, R; Fawcett, J1
Aizawa, H; Ayabe, M; Hauser, M; Kida, H; Miura, S; Nagasato, K; Nakajima, J; Noda, K; Taniwaki, T1

Reviews

1 review(s) available for pramipexole and Anhedonia

ArticleYear
What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?
    Translational psychiatry, 2016, Mar-08, Volume: 6

    Topics: Anhedonia; Animals; Anxiety; Apathy; Behavior, Animal; Benzothiazoles; Depression; Disease Models, Animal; Dopamine Agonists; Mice; Neostriatum; Parkinson Disease; Pramipexole; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Substantia Nigra

2016

Trials

1 trial(s) available for pramipexole and Anhedonia

ArticleYear
Add-on pramipexole for anhedonic depression: study protocol for a randomised controlled trial and open-label follow-up in Lund, Sweden.
    BMJ open, 2023, Nov-30, Volume: 13, Issue:11

    Topics: Anhedonia; Depression; Follow-Up Studies; Humans; Pramipexole; Randomized Controlled Trials as Topic; Sweden

2023

Other Studies

4 other study(ies) available for pramipexole and Anhedonia

ArticleYear
Rapid Treatment of Anhedonia With Pramipexole as Adjunct to Buprenorphine in Opioid Use Disorder.
    The primary care companion for CNS disorders, 2023, 10-26, Volume: 25, Issue:5

    Topics: Anhedonia; Buprenorphine; Humans; Narcotic Antagonists; Opioid-Related Disorders; Pramipexole

2023
Dopaminergic Receptors as Neuroimmune Mediators in Experimental Autoimmune Encephalomyelitis.
    Molecular neurobiology, 2021, Volume: 58, Issue:11

    Topics: Anhedonia; Animals; Axons; Brain-Derived Neurotrophic Factor; Corpus Striatum; Depression; Disease Progression; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Interleukin-1beta; Lymph Nodes; Mice; Mice, Inbred C57BL; Neuroinflammatory Diseases; Oxidative Stress; Peptide Fragments; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Single-Blind Method; Spinal Cord

2021
Pramipexole in Treatment Resistant-Depression, Possible Role of Inflammatory Cytokines.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017, Volume: 42, Issue:1

    Topics: Anhedonia; Animals; Antidepressive Agents; Benzothiazoles; Cytokines; Depressive Disorder, Treatment-Resistant; Humans; Pramipexole

2017
Anhedonia in Japanese patients with Parkinson's disease: analysis using the Snaith-Hamilton Pleasure Scale.
    Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:4

    Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Anhedonia; Antiparkinson Agents; Benzothiazoles; Female; Humans; Japan; Linear Models; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pleasure; Pramipexole; Sex Factors

2012